Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Richardson, K. A.
Right arrow Articles by van Sittert, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardson, K. A.
Right arrow Articles by van Sittert, N. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences, Vol 49, 186-201, Copyright © 1999 by Society of Toxicology


ARTICLES

Quantitative and qualitative differences in the metabolism of 14C-1,3- butadiene in rats and mice: relevance to cancer susceptibility

KA Richardson, MM Peters, BA Wong, RH Megens, PA van Elburg, ED Booth, PJ Boogaard, JA Bond, MA Medinsky, WP Watson and NJ van Sittert
Shell International Chemicals, Toxicology Department, Shell Research and Technology Centre Amsterdam, The Netherlands.

1,3-Butadiene (butadiene) is a potent carcinogen in mice, but not in rats. Metabolic studies may provide an explanation of these species differences and their relevance to humans. Male Sprague-Dawley rats and B6C3F1 mice were exposed for 6 h to 200 ppm [2,3-14C]-butadiene (specific radioactivity [sa] 20 mCi/mmol) in a Cannon nose-only system. Radioactivity in urine, feces, exhaled volatiles and 14C-CO2 were measured during and up to 42 h after exposure. The total uptake of butadiene by rats and mice under these experimental conditions was 0.19 and 0.38 mmol (equivalent to 3.8 and 7.5 mCi) per kg body weight, respectively. In the rat, 40% of the recovered radioactivity was exhaled as 14C-CO2, 70% of which was trapped during the 6-h exposure period. In contrast, only 6% was exhaled as 14C-CO2 by mice, 3% during the 6-h exposure and 97% in the 42 h following cessation of exposure. The formation of 14C-CO2 from [2,3-14C]-labeled butadiene indicated a ready biodegradability of butadiene. Radioactivity excreted in urine accounted for 42% of the recovered radioactivity from rats and 71% from mice. Small amounts of radioactivity were recovered in feces, exhaled volatiles and carcasses. Although there was a large measure of commonality, the exposure to butadiene also led to the formation of different metabolites in rats and mice. These metabolites were not found after administration of [4-14C]-1,2-epoxy-3-butene to animals by i.p. injection. The results show that the species differences in the metabolism of butadiene are not simply confined to the quantitative formation of epoxides, but also reflect a species-dependent selection of metabolic pathways. No metabolites other than those formed via an epoxide intermediate were identified in the urine of rats or mice after exposure to 14C-butadiene. These findings may have relevance for the prediction of butadiene toxicity and provide a basis for a revision of the existing physiologically based pharmacokinetic models.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M.W. Powley, Y. Li, P.B. Upton, V.E. Walker, and J.A. Swenberg
Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol
Carcinogenesis, September 1, 2005; 26(9): 1573 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. L. Sprague, L. A. Phillips, K. M. Young, and A. A. Elfarra
Species and Tissue Differences in the Toxicity of 3-Butene-1,2-diol in Male Sprague-Dawley Rats and B6C3F1 Mice
Toxicol. Sci., July 1, 2004; 80(1): 3 - 13.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. L. Sprague and A. A. Elfarra
DETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENE
Drug Metab. Dispos., August 1, 2003; 31(8): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
N. J. van Sittert, H. J. J. J. Megens, W. P. Watson, and P. J. Boogaard
Biomarkers of Exposure to 1,3-Butadiene as a Basis for Cancer Risk Assessment
Toxicol. Sci., July 1, 2000; 56(1): 189 - 202.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.